SCHEMBL20340083

SCHEMBL20340083

N#Cc1c(-c2cccs2)cc(=O)[nH]c1SCc1cccc(-c2nnn[nH]2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 7/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ KDM4E B2RXH2 5/20 0.40
▸ PIM1 P11309 2/20 0.40
▸ KMT2A Q03164 5/20 0.38
▸ MAPT P10636 5/20 0.38
▸ ALDH1A1 P00352 4/20 0.38
▸ NPSR1 Q6W5P4 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ ADORA2A P29274 3/20 0.38
▸ ADORA1 P30542 3/20 0.38
▸ POLB P06746 3/20 0.38
▸ HPGD P15428 2/20 0.38
▸ PRNP P04156 2/20 0.38
▸ RXFP1 Q9HBX9 2/20 0.38
▸ USP2 O75604 1/20 0.38
▸ PKM P14618 1/20 0.38
▸ BLM P54132 1/20 0.38
▸ SAE1 Q9UBE0 1/20 0.38
▸ UBA2 Q9UBT2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20340181 0.87 KMT2A (0.42) ACMSDCYP2C19KDM4EKMT2AMAPT
SCHEMBL23852405 0.87 ACMSD (0.52) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL24088040 0.86 ACMSD (0.44) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL20339912 0.86 ACMSD (0.44) ACMSDCYP2C19KDM4EKMT2AMEN1
SCHEMBL24088014 0.84 ACMSD (0.68) ACMSDCYP2C19KDM4EPIM1KMT2A
SCHEMBL20339819 0.84 BRD4 (0.40) ACMSDCYP2C19KDM4EKMT2AMAPT
SCHEMBL26404249 0.83 ALDH1A1 (0.47) ACMSDCYP2C19KDM4EKMT2AMAPT
SCHEMBL32688007 0.82 ACMSD (0.49) ACMSDKMT2AALDH1A1MEN1ADORA2A
SCHEMBL20340099 0.81 KMT2A (0.40) ACMSDCYP2C19KDM4EKMT2AMAPT
SCHEMBL20340093 0.81 KDM4E (0.48) ACMSDCYP2C19KDM4EPIM1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12378200-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2025-08-05 — — US disclosed
US-20250145572-A1 Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors ORSOBIO INC (US) 2025-05-08 — — US disclosed
US-20240059657-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS OrsoBio Inc. 2024-02-22 — — US disclosed
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ORSOBIO, INC. (US) 2023-10-10 — — US disclosed
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ORSOBIO, INC. 2021-04-01 — — US disclosed
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ORSOBIO, INC. 2021-04-01 — — US disclosed
WO-2018125983-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS MITOBRIDGE, INC. (US) 2018-07-05 — — WO disclosed
WO-2018125983-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS MITOBRIDGE, INC. (US) 2018-07-05 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12378200-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 ACMSD 2/4885CYP2C19 644/4885KDM4E 1040/4885
US-20250145572-A1 Aminocarboxymuconate Semialdehyde Decarboxylase (ACMSD) Inhibitors ACMSD, ALDH7A1, ALAD ACMSD 1/4885CYP2C19 471/4885KDM4E 807/4885
US-20240059657-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ALDH7A1, ACMSD, AMD1 ACMSD 2/4885CYP2C19 644/4885KDM4E 1040/4885
US-20210094916-A1 OXOPYRIDINE DERIVATIVES USEFUL AS AMINOCARBOXYMUCONATE SEMIALDEHYDE DECARBOXYLASE (ACMSD) INHIBITORS ALDH7A1, OTC, DDC ACMSD 8/4885CYP2C19 727/4885KDM4E 1198/4885
US-11780812-B2 Oxopyridine derivatives useful as aminocarboxymuconate semialdehyde decarboxylase (ACMSD) inhibitors ALDH7A1, ACMSD, AMD1 ACMSD 2/4885CYP2C19 644/4885KDM4E 1040/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback